Kevin Lee Chen

Biography

Education and Training

• BS, Statistics and Analytics
  University of North Carolina at Chapel Hill
• PhD, Biostatistics
  Harvard University

Publications

• Effect of Mannitol on Cisplatin-Associated AKI: A Target Trial Emulation.

  Gupta S, Glezerman IG, Hirsch JS, Wells SL, Chen KL, Seitter RH, Monson AE, Green-Lingren O, Jhaveri KD, Page VD, Abramson MH, Bansal A, Abudayyeh A, Leaf DE. Nephrol Dial Transplant 2024 Oct 16

• F18-FDG PET imaging as a diagnostic tool for immune checkpoint inhibitor-associated acute kidney injury.

  Gupta S, Green-Lingren O, Bhimaniya S, Krokhmal A, Jacene H, Ostermann M, Chicklore S, Sprangers B, Deroose CM, Herrmann SM, Wells SL, Kaunfer SA, Ortega JL, García-Carro C, Bold M, Chen KL, Sise ME, Heidari P, Pak WLW, Lee MD, Beckerman P, Eshet Y, Hsu RK, Hernandez Pampaloni M, Rashidi A, Avril N, Donley V, Mithani Z, Kuker R, Awiwi MO, Wang MX, Shah SI, Weintraub MD, Schoder H, Chowdhury RB, Seethapathy H, Reynolds KL, Soler MJ, Abudayyeh A, Glezerman I, Leaf DE. J Clin Invest 2024 Aug 08

• Derivation and external validation of a simple risk score for predicting severe acute kidney injury after intravenous cisplatin: cohort study.

  Gupta S, Glezerman IG, Hirsch JS, Chen KL, Devaraj N, Wells SL, Seitter RH, Kaunfer SA, Jose AM, Rao SP, Ortega JL, Green-Lingren O, Hayden R, Bendapudi PK, Chute DF, Sise ME, Jhaveri KD, Page VD, Abramson MH, Motwani SS, Xu W, Sehgal K, Reynolds KL, Bansal A, Abudayyeh A, Leaf DE. BMJ 2024 03 27

• Risk Factors for Severe Hypertension and Proteinuria After Treatment With Vascular Endothelial Growth Factor Signaling Pathway Inhibitors Among Patients With Cancer.

  Hanna PE, Anumolu RK, Motwani SS, Chen KL, Katz-Agranov N, Green-Lingren O, Yilmam OA, Jhaveri KD, Kitchlu A, Kala J, Sise ME, Gupta S. Kidney Int Rep 2024

• Differential impacts of COVID-19 lockdowns on PM 2.5 across the United States.

  Chen KL, Henneman LRF, Nethery RC. Environ Adv 2021